These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Urinary incontinence: new pharmacologic therapies].
    Author: Robles García JE, Zudaire Bergera JJ, Rosell Costa D, Berián Polo JM.
    Journal: Rev Med Univ Navarra; 2004; 48(4):43-9. PubMed ID: 15812946.
    Abstract:
    Several classes of drugs have been investigated for their efficacy in treating overactive bladder syndrome (OAB) and stress urinary incontinence (SUI). Surgery and behavioral therapies are currently the mainstay of treating SUI. However, results are also being made available about a new oral medication, Duloxetine, which appears to be clinically safe and effective for the treatment of SUI. On the other hand, a new muscarinic receptor antagonist, Solifenacin, has been shown in clinical trials to be clinically effective, safe and well tolerated for treating OAB.
    [Abstract] [Full Text] [Related] [New Search]